Nautilus Biotechnology (NAUT)
(Delayed Data from NSDQ)
$2.69 USD
+0.05 (1.89%)
Updated May 24, 2024 03:59 PM ET
After-Market: $2.69 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Nautilus Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -63.68 | -57.92 | -50.32 | -0.52 | NA |
Depreciation/Amortization & Depletion | 3.05 | 2.53 | 3.03 | 0.00 | NA |
Net Change from Assets/Liabilities | -3.22 | -0.79 | -0.02 | 0.01 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 12.14 | 10.38 | 8.07 | -0.04 | NA |
Net Cash From Operating Activities | -51.71 | -45.81 | -39.24 | -0.55 | NA |
Property & Equipment | -2.44 | -2.32 | -2.27 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | -41.29 | -23.42 | -136.70 | -149.50 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -43.74 | -25.74 | -138.96 | -149.50 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.37 | 0.56 | 0.17 | 0.00 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 335.41 | -0.06 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | -8.13 | 151.11 | NA |
Net Cash from Financing Activities | 0.37 | 0.56 | 327.45 | 151.05 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -95.08 | -70.98 | 149.24 | 1.00 | NA |
Cash at Beginning of Period | 115.48 | 186.46 | 37.22 | 0.00 | NA |
Cash at End of Period | 20.40 | 115.48 | 186.46 | 1.00 | NA |
Diluted Net EPS | -0.51 | -0.46 | -0.60 | -0.15 | NA |
Fiscal Year End for Nautilus Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -18.73 | -63.68 | -46.65 | -30.77 | -14.97 |
Depreciation/Amortization & Depletion | 0.84 | 3.05 | 2.08 | 1.22 | 0.50 |
Net Change from Assets/Liabilities | -1.49 | -3.22 | -2.30 | -2.48 | -0.92 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.11 | 12.14 | 9.06 | 5.96 | 2.86 |
Net Cash From Operating Activities | -16.27 | -51.71 | -37.81 | -26.07 | -12.52 |
Property & Equipment | -0.65 | -2.44 | -2.03 | -1.16 | -0.69 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 23.00 | -41.29 | -0.65 | -14.60 | -12.80 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 22.35 | -43.74 | -2.68 | -15.75 | -13.50 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.25 | 0.37 | 0.12 | 0.10 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.25 | 0.37 | 0.12 | 0.10 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 6.33 | -95.08 | -40.37 | -41.72 | -26.02 |
Cash at Beginning of Period | 20.40 | 115.48 | 115.48 | 115.48 | 115.48 |
Cash at End of Period | 26.73 | 20.40 | 75.11 | 73.75 | 89.46 |
Diluted Net EPS | -0.15 | -0.13 | -0.13 | -0.13 | -0.12 |